Terms: = Sarcomas AND ETV1, DKFZp781L0674, 2115, ENSG00000006468, ER81, MGC120533, MGC104699, MGC120534 AND Treatment
13 results:
1. Development and characterization of an etv1 rabbit monoclonal antibody for the immunohistochemical detection of etv1 expression in cancer tissue specimens.
Schafer C; Young D; Singh H; Jayakrishnan R; Banerjee S; Song Y; Dobi A; Petrovics G; Srivastava S; Srivastava S; Sesterhenn IA; Chesnut GT; Tan SH
J Immunol Methods; 2023 Jul; 518():113493. PubMed ID: 37196930
[TBL] [Abstract] [Full Text] [Related]
2. Proton therapy with a fixed beamline for skull-base chordomas and chondrosarcomas: outcomes and toxicity.
Gordon K; Gulidov I; Koryakin S; Smyk D; Makeenkova T; Gogolin D; Lepilina O; Golovanova O; Semenov A; Dujenko S; Medvedeva K; Mardynsky Y
Radiat Oncol; 2021 Dec; 16(1):238. PubMed ID: 34930352
[TBL] [Abstract] [Full Text] [Related]
3. The V654A second-site KIT mutation increases tumor oncogenesis and STAT activation in a mouse model of gastrointestinal stromal tumor.
Zhang JQ; Bosbach B; Loo JK; Vitiello GA; Zeng S; Seifert AM; Medina BD; Param NJ; Maltbaek JH; Rossi F; Antonescu CR; Besmer P; DeMatteo RP
Oncogene; 2020 Dec; 39(49):7153-7165. PubMed ID: 33024275
[TBL] [Abstract] [Full Text] [Related]
4. Is treatment at a High-volume Center Associated with an Improved Survival for Primary Malignant Bone Tumors?
Malik AT; Alexander JH; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2020 Mar; 478(3):631-642. PubMed ID: 31714413
[TBL] [Abstract] [Full Text] [Related]
5. A novel PTPRZ1-etv1 fusion in gliomas.
Matjašič A; Zupan A; Boštjančič E; Pižem J; Popović M; Kolenc D
Brain Pathol; 2020 Mar; 30(2):226-234. PubMed ID: 31381204
[TBL] [Abstract] [Full Text] [Related]
6. Identification of phenothiazine as an etv1‑targeting agent in gastrointestinal stromal tumors using the Connectivity Map.
Yen CC; Chen LT; Li CF; Chen SC; Chua WY; Lin YC; Yen CH; Chen YC; Yang MH; Chao Y; Fletcher JA
Int J Oncol; 2019 Aug; 55(2):536-546. PubMed ID: 31268158
[TBL] [Abstract] [Full Text] [Related]
7. Blood neutrophil-to-lymphocyte ratio is associated with prognosis in advanced gastrointestinal stromal tumors treated with imatinib.
Rutkowski P; Teterycz P; Klimczak A; Bylina E; Szamotulska K; Lugowska I
Tumori; 2018 Dec; 104(6):415-422. PubMed ID: 29714669
[TBL] [Abstract] [Full Text] [Related]
8. Gastrointestinal stromal tumor of unusual phenotype after imatinib treatment: A case report and diagnostic utility of etv1 mRNA in situ hybridization.
Jung M; Park SH; Jeon YK; Won JK; Yang HK; Kim WH
Medicine (Baltimore); 2017 Dec; 96(49):e9031. PubMed ID: 29245294
[TBL] [Abstract] [Full Text] [Related]
9. Emerging drugs for the treatment of gastrointestinal stromal tumour.
Kasireddy V; von Mehren M
Expert Opin Emerg Drugs; 2017 Dec; 22(4):317-329. PubMed ID: 29183145
[TBL] [Abstract] [Full Text] [Related]
10. A small molecule inhibitor of etv1, YK-4-279, prevents prostate cancer growth and metastasis in a mouse xenograft model.
Rahim S; Minas T; Hong SH; Justvig S; Çelik H; Kont YS; Han J; Kallarakal AT; Kong Y; Rudek MA; Brown ML; Kallakury B; Toretsky JA; Üren A
PLoS One; 2014; 9(12):e114260. PubMed ID: 25479232
[TBL] [Abstract] [Full Text] [Related]
11. YK-4-279 inhibits ERG and etv1 mediated prostate cancer cell invasion.
Rahim S; Beauchamp EM; Kong Y; Brown ML; Toretsky JA; Üren A
PLoS One; 2011 Apr; 6(4):e19343. PubMed ID: 21559405
[TBL] [Abstract] [Full Text] [Related]
12. treatment of Ewing's sarcoma using an antisense oligodeoxynucleotide to regulate the cell cycle.
Asami S; Chin M; Shichino H; Yoshida Y; Nemoto N; Mugishima H; Suzuki T
Biol Pharm Bull; 2008 Mar; 31(3):391-4. PubMed ID: 18310898
[TBL] [Abstract] [Full Text] [Related]
13. Pediatric brachytherapy. The St. Jude Children's Research Hospital experience.
Fontanesi J; Rao BN; Fleming ID; Bowman LC; Pratt CB; Furman WL; Coffey DH; Kun LE
Cancer; 1994 Jul; 74(2):733-9. PubMed ID: 8033055
[TBL] [Abstract] [Full Text] [Related]
